Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page's revision history.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations for several German states were added (Baden-Wurttemberg, Bavaria, Hesse, North Rhine-Westphalia, Rhineland-Palatinate, Saxony-Anhalt, State of Berlin) and corresponding blocks removed; the revision shows as v3.3.3.SummaryDifference0.8%

- Check53 days agoChange DetectedThe Publications note now states that PubMed publications are automatically filled and may not pertain to the study. The page revision version was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding/operating status banner from the Study Details page; core study information, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedThe new screenshot shows only minor formatting edits to the study details page and no changes to core study content (eligibility criteria, study arms, outcomes, or locations); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange Detected- Added a government-operation notice and status links, clarifying potential delays and current NIH Clinical Center openness. - Removed the previous version tag (v3.1.0) and introduced v3.2.0.SummaryDifference3%

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.